Interleukin-6, C-reactive protein, fibrinogen, and risk of recurrence after ischaemic stroke: Systematic review and

J J McCabe1,2,3,4, E O'Reilly1, S Coveney1,2,5

  • 1Health Research Board (HRB) Stroke Clinical Trials Network Ireland (SCTNI), Dublin, Ireland.

Insights

Inflammatory markers like C-reactive protein and fibrinogen are linked to recurrent stroke and major vascular events. Further research is needed to clarify their prognostic role and guide anti-inflammatory therapies.

Area of Science:

  • Cardiovascular Medicine
  • Neuroscience
  • Biomarkers

Background:

  • Anti-inflammatory therapies show promise in coronary disease but are understudied in stroke.
  • The prognostic value of inflammatory markers post-stroke is unclear, and current guidelines do not recommend their routine use for risk stratification.

Purpose of the Study:

  • To systematically review and meta-analyze the association between key inflammatory markers and the risk of recurrent stroke or major vascular events (MVEs).
  • To evaluate the prognostic significance of C-reactive protein (CRP), interleukin-6 (IL-6), and fibrinogen in stroke survivors.

Main Methods:

  • A systematic review of EMBASE and Ovid Medline databases was conducted up to October 1, 2019.
  • Random-effects meta-analysis was performed on studies reporting comparable effect measures for CRP, IL-6, and fibrinogen.
  • Included studies investigated the association between these markers and recurrent stroke or MVEs.

Main Results:

  • Of 2,515 identified reports, 39 met eligibility criteria.
  • C-reactive protein (CRP) was significantly associated with an increased risk of recurrent stroke (HR 1.14 per SD increase) and MVEs (HR 1.21 per SD increase).
  • Fibrinogen also showed a significant association with recurrent stroke (HR 1.26) and MVEs (HR 1.31). Trends for IL-6 were observed but did not reach statistical significance.

Conclusions:

  • Evidence suggests an association between inflammatory markers and post-stroke vascular recurrence, but significant methodological heterogeneity exists.
  • Individual-patient data pooling and standardized methods are crucial to definitively establish the prognostic role of these markers.
  • Improved understanding may aid patient selection for future anti-inflammatory therapy trials in stroke.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
319
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.2K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.7K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.2K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
97
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
202